Frontlight ResearchEarly access
Trial site
310 Clinical Research
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Heart failure1 trial
- Liver cirrhosis1 trial
- Long COVID and ME/CFS1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Amgen3 trials
- Boehringer Ingelheim2 trials
- Celldex Therapeutics2 trials
- AIM ImmunoTech Inc.1 trial
- Gilead Sciences1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Heart failure1 recruiting
- Liver cirrhosis1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026